Please read the full information about warnings for Indivina detailed in your Patient Information Leaflet.
You should also talk to your doctor before attempting to stop Indivina.
You should contact a doctor if you experience unusual bleeding when on this product
You should go for regular breast screening and smear tests.
You should also check your breasts regularly and see your doctor if you notice changes such as dimpling of the skin, nipple changes or you can see or feel any lumps.
There is an increased risk of risk of developing blood clots with HRT tablets. You should stop taking Indivina and see a doctor if you notice signs of a blood clot.
HRT
One tablet should be taken daily, at around the same time each day. There should be no tablet-free days while using.
ensure to take it within the next 12 hours. If it has already been more than 12 hours, start as normal by the next day.
it may increase the risk of there being breakthrough bleeding and spotting. Do not attempt to take a double dose.
It is recommended to start on a lower dose and increase if necessary. Please seek further advice if you need support with this.
If you have, have had breast cancer or cancer of the uterus or other oestrogen-sensitive cancers.
If you have unexplained vaginal bleeding.
If you have or have ever had a blood clot in a vein.
If you have a blood clotting disorder.
If you have or have ever had a liver disease and your liver function tests have not returned to normal.
Untreated endometrial hyperplasia
If you have porphyria.
Weight gain or weight loss.
Fluid retention
Depression, nervousness, fatigue
Headache
Hot flushes, sweating.
Nausea/Vomiting
Breast tenderness and pain
Vaginal discharge
Bleeding or spotting
Lactose monohydrate, maize starch, gelatin, magnesium stearate
Store below 25°C
